Patricia A. Johnson, MD, PhD

Rush-Copley Cancer Care CenterAurora, Illinois - 60504 (217-383-3019) |
- CLINICAL TRIALS 4
- CONDITIONS6
- INTERVENTIONS9
- SINCE2005

Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
March 2005 - June 2015

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
November 2008 - August 2011

Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013

Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
October 2006 - September 2011
Breast Neoplasms
Carcinoma
Carcinoma in Situ
Carcinoma, Intraductal, Noninfiltrating
Carcinoma, Ductal, Breast
Carcinoma, Ductal
Placebo
Paclitaxel
Bevacizumab
Cyclophosphamide
Radiation Therapy
Doxorubicin Hydrochloride
Trastuzumab
Ac Regimen
Chemotherapy



